February 2001
BRIDGING WORLDS
While health plans have embraced alternative therapies, there's little agreement on how to bill for them. The ability to demonstrate outcomes may help.
Cover Story
There's a difference between plausibility and wishful thinking that many who predict the advent of this system fail to recognize. Risk adjusting, adverse selection, and the tax code present hurdles.
COST EFFICIENCY
Despite what might be commonly believed, pharmacoeconomics is not a widely used tool for formulary development. Here's a model to follow.
RED TAPE DEPT.
When it comes to information-sharing, just when does 'no' mean 'no'? What about conflicting statutes? We have two years to sort it out.
Q&A
Unintentional bias can be just as damaging as the overt brand, according to the president of the National Medical Association.
Compensation Monitor
Editor’s Memo
Managed Care Outlook
State Initiatives
Systems & Software
Washington Watch
Follow us
Today's popular content
- How Doctors Are Paid Now, And Why It Has to Change
- Specialty Pharmacy Management Will Become More Intense
- What the Primary Care Physician Shortage Means for Health Plans
- Occupy the OR
- Through the Looking Glass
- Transparency Called Key To Uniting Cost Control, Quality Improvement
- Health Plans Can Learn From VHA Turnaround
- It's To Plans' Benefit To Spell Out Authority
- Large employers agree on rewarding healthy behavior
- Insurers skeptical of usefulness of companion diagnostics
Recent blog posts
- Health Care Industry’s Moment of Truth Is Approaching
- Through the Looking Glass
- Physician Practices Hiring Care Coordinators
- Who Will Pay for High-Cost Biologics?
- Health exchanges stumble to the starting line
- It's Elementary
- Yet Another Warning About Antibiotic Overprescribing
- Let the EMR Backlash Begin
- Not a Third World Experience
- UK: Health Care Policy Mayhem…and a Very Public Scandal
